Predicted to enable mRNA binding activity and mRNA m(6)A methyltransferase activity. Involved in response to nutrient levels. Predicted to be located in nucleoplasm. Predicted to be part of RNA N6-methyladenosine methyltransferase complex. Predicted to be active in nucleus. Biomarker of traumatic brain injury. Orthologous to human METTL14 (methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit); INTERACTS WITH all-trans-retinoic acid; azoxystrobin; bisphenol A.
LOC295428; methyltransferase 14, N6-adenosine-methyltransferase subunit; methyltransferase like 14; methyltransferase-like protein 14; N6-adenosine-methyltransferase non-catalytic subunit; N6-adenosine-methyltransferase subunit METTL14; RGD1304822; similar to KIAA1627 protein
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 mRNA and mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 protein
METTL14 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA] and mono-(2-ethylhexyl)phthalate affects the reaction [METTL14 protein affects the expression of SCARB1 mRNA]
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 mRNA] and Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 protein]
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 mRNA] and Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 protein]
3-deazaadenosine inhibits the reaction [thallium acetate results in increased expression of METTL14 protein] and METTL14 protein affects the reaction [thallium acetate results in increased expression of ATP13A3 protein]
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA